IO Biotech, Inc.
IOBT
$0.64
$0.011.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 68.04% | -16.93% | 28.44% | -30.47% | -16.09% |
| Total Depreciation and Amortization | -1.71% | 3.08% | 3.65% | 6.83% | -4.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -257.27% | 187.99% | -73.43% | 12,017.31% | -97.00% |
| Change in Net Operating Assets | -305.07% | 152.53% | -149.17% | 75.86% | 67.90% |
| Cash from Operations | 6.78% | 14.08% | -17.56% | 5.69% | -22.53% |
| Capital Expenditure | 84.62% | 7.14% | -154.55% | -10.00% | 16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 84.62% | 7.14% | -154.55% | -10.00% | 16.67% |
| Total Debt Issued | 25.55% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.27% | -- | -- | -- | -- |
| Cash from Financing | 85.17% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 57.07% | -485.71% | 129.73% | -302.34% | 206.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.29% | 60.97% | -13.85% | 1.98% | -19.30% |